메뉴 건너뛰기




Volumn 11, Issue 7, 2006, Pages 306-308

Fabry disease in a female patient due to a de novo point mutation at position 691 of exon 5

Author keywords

galactosidase A; Fabry disease; Heterozygous

Indexed keywords

AGALSIDASE ALFA; ALPHA GALACTOSIDASE; ASPARAGINE; ASPARTIC ACID;

EID: 33747325490     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (8)

References (6)
  • 1
    • 0348149005 scopus 로고    scopus 로고
    • Enzyme replacement therapy in heterozygous females with Fabry disease: Results of a phase IIIB study
    • Baehner F, Kampmann C, Whybra C, Miebach E, Wiethoff CM, Beck MJ (2003) Enzyme replacement therapy in heterozygous females with Fabry disease: results of a phase IIIB study. J Inherit Metab Dis 26: 617-627
    • (2003) J Inherit Metab Dis , vol.26 , pp. 617-627
    • Baehner, F.1    Kampmann, C.2    Whybra, C.3    Miebach, E.4    Wiethoff, C.M.5    Beck, M.J.6
  • 6
    • 19244364584 scopus 로고    scopus 로고
    • Uneven X inactivation in a female monozygotic twin pair with Fabry disease and discordant expression of a novel mutation in the α-galactosidase A gene
    • Redonnet-Vernhet I, Ploos van Amstel JK, Jansen RP, Wevers RA, Salvayre R, Levade T (1996) Uneven X inactivation in a female monozygotic twin pair with Fabry disease and discordant expression of a novel mutation in the α-galactosidase A gene. J Med Genet 33: 682-688
    • (1996) J Med Genet , vol.33 , pp. 682-688
    • Redonnet-Vernhet, I.1    Ploos van Amstel, J.K.2    Jansen, R.P.3    Wevers, R.A.4    Salvayre, R.5    Levade, T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.